

There are parts of the stock market where I am comfortable doing the research myself.Give me a community bank’s balance sheet, loan portfolio, and deposit...
You can purchase shares of iBio (NASDAQ:IBIO) through any online brokerage.
Other companies in iBio’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
iBio has a consensus price target of $5.08.
The stock price for iBio (NASDAQ: IBIO) is $0.745 last updated October 30, 2026 at 2:20 PM EDT.
There are no upcoming dividends for iBio.
iBio does not have any upcoming earnings scheduled.
There is no upcoming split for iBio.
iBio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
iBio Inc is a clinical-stage biotechnology company using Artificial Intelligence (AI) for the development of hard-to-drug precision antibodies for obesity, cardiometabolic, and cardiopulmonary diseases. Its product candidate pipeline includes...